Trends in Immunology. 2023; 44(11); 890-901
Pharmaceutics. 2022; 14(6); 1201
HPMA copolymer mebendazole conjugate allows systemic administration and possesses antitumour activity in vivo
Nanomedicine: Nanotechnology; Biology and Medicine. 2022; 44(August); 102578
Metastatic spread inhibition of cancer cells through stimuli-sensitive HPMA copolymer-bound actinonin nanomedicines
In: Biografický slovník českých zemí. Sešit 25. Hl-Hol. Praha: Academia; 2022; s. 796-797
Holub; Miroslav
Frontiers in Immunology. 2022; 13(OCT 10 2022); 989895
SOT101 induces NK cell cytotoxicity and potentiates antibody-dependent cell cytotoxicity and anti-tumor activity
Pharmaceutics. 2021; 13(2); 179
HPMA-based copolymers carrying STAT3 inhibitor cucurbitacin-D as stimulus-sensitive nanomedicines for oncotherapy
Oncoimmunology. 2021; 10(1); 1889822
TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
Journal of Controlled Release. 2021; 332(APR 10 2021); 563-580
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
eLife. 2021; 10(MAY 18 2021); e65777